Skip to main content

Site notifications

Points to consider on the non-clinical assessment of the carcinogenic potential of insulin analogues

We have adopted this International Scientific Guideline - CPMP/SWP/372/01

Last updated

Help us improve the Therapeutic Goods Administration site